Journal article icon

Journal article

Cardiolipin, and not monolysocardiolipin, preferentially binds to the interface of complexes III and IV

Abstract:
The mitochondrial electron transport chain comprises a series of protein complexes embedded in the inner mitochondrial membrane that generate a proton motive force via oxidative phosphorylation, ultimately generating ATP. These protein complexes can oligomerize to form larger structures called supercomplexes. Cardiolipin (CL), a conical lipid, unique within eukaryotes to the inner mitochondrial membrane, has proven essential in maintaining the stability and function of supercomplexes. Monolysocardiolipin (MLCL) is a CL variant that accumulates in people with Barth syndrome (BTHS). BTHS is caused by defects in CL biosynthesis and characterised by abnormal mitochondrial bioenergetics and destabilised supercomplexes. However, the mechanisms by which MLCL causes pathogenesis remain unclear. Here, multiscale molecular dynamics characterise the interactions of CL and MLCL with yeast and mammalian mitochondrial supercomplexes containing complex III (CIII) and complex IV (CIV). Coarse-grained simulations reveal that both CL and MLCL bind to sites at the interface between CIII and CIV of the supercomplex. Free energy perturbation calculations show that MLCL interaction is weaker than that of CL and suggest that interaction with CIV drives this difference. Atomistic contact analyses show that, although interaction with CIII is similar for CL and MLCL, CIV makes more contacts with CL than MLCL, demonstrating that CL is a more successful “glue” between the two complexes. Simulations of the human CIII2CIV supercomplex show that this interface site is maintained between species. Our study suggests that MLCL accumulation in people with BTHS disrupts supercomplex stability by formation of relatively weak interactions at the interface lipid binding site
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-1820-7993
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-6360-7959
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-9873-4552


More from this funder
Funder identifier:
10.13039/100010269
Grant:
208361/Z/17/Z
More from this funder
Funder identifier:
10.13039/501100000265
Grant:
MR/S009213/1
More from this funder
Funder identifier:
10.13039/501100000266
Grant:
EP/R029407/1
More from this funder
Funder identifier:
10.13039/501100000268
Grant:
BB/P01948X/1


Publisher:
Royal Society of Chemistry
Journal:
Chemical Science More from this journal
Volume:
13
Issue:
45
Pages:
13489-13498
Publication date:
2022-11-23
DOI:
EISSN:
2041-6539
ISSN:
2041-6520


Language:
English
Keywords:
Pubs id:
1308188
Local pid:
pubs:1308188
Source identifiers:
W4311291543
Deposit date:
2026-04-30
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP